![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/10/2879583/0/en/Eterna-Therapeutics-to-Present-at-the-ASGCT-27th-Annual-Meeting-on-Development-of-Beta-2-Microglobulin-Knockout-B2M-KO-iMSC-Line-with-Enhanced-Immunosuppressive-Activity-and-Stealt.html
https://www.globenewswire.com/news-release/2024/05/08/2877930/0/en/Eterna-Therapeutics-Announces-Appointment-of-Mahendra-Rao-PhD-to-its-Scientific-Advisory-Board.html
https://www.globenewswire.com/news-release/2024/05/07/2876675/0/en/Eterna-Therapeutics-to-Present-at-the-ASGCT-27th-Annual-Meeting-on-the-Development-of-a-mRNA-Engineered-iPSC-Line-which-Mimics-Native-B2M-Expression-via-Targeted-Insertion-of-HLA-E.html
https://www.globenewswire.com/news-release/2024/05/07/2876680/0/en/Eterna-Therapeutics-to-Present-at-the-ASGCT-27th-Annual-Meeting-on-Development-of-Beta-2-Microglobulin-Knockout-B2M-KO-iMSC-Line-with-Enhanced-Immunosuppressive-Activity-and-Stealt.html
https://www.globenewswire.com//news-release/2024/02/20/2831849/0/en/Eterna-Therapeutics-Announces-the-Appointment-of-Peter-Cicala-JD-to-its-Board-of-Directors.html
https://www.globenewswire.com//news-release/2024/01/03/2803636/0/en/Eterna-Therapeutics-Grants-New-President-and-CEO-Sanjeev-Luther-Inducement-Award-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com//news-release/2023/12/20/2799652/0/en/Eterna-Therapeutics-Names-Sanjeev-Luther-as-President-and-Chief-Executive-Officer.html
https://www.globenewswire.com//news-release/2023/12/14/2796781/0/en/Eterna-Therapeutics-Announces-9-2-Million-Convertible-Debt-and-Warrant-Financing.html
https://www.globenewswire.com//news-release/2023/11/01/2771173/0/en/Eterna-Therapeutics-Appoints-James-Bristol-Ph-D-Pharmaceutical-Research-and-Drug-Discovery-Veteran-to-Board-of-Directors.html
https://www.globenewswire.com//news-release/2023/09/06/2738354/0/en/Eterna-Therapeutics-Announces-Initiation-of-Development-Activities-for-Hypoimmune-Pluripotent-Cell-Line-for-Neurology-Indications-Under-Partnership-With-Lineage-Cell-Therapeutics.html